Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by FireStarter1980on Mar 23, 2018 10:51am

158 Views

Post# 27769681

New Age Farms Greenhouses Won't Be Up To Par

Does anyone actually believe that there will be a shortage of marijuana to the point that a large provider would rent these greenhouses to grow a little extra. There are strict standards in product and conditions the products are grown. Reputations to the big guys will be paramount.

No one will sell Aurora branded marijuana grown in some rental farm.

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale